一种新型的基于受体结合域（RBD）的抗SARS-CoV-2 mRNA疫苗。 - Suppr

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.

作者信息

Tai Wanbo, Zhang Xiujuan, Drelich Aleksandra, Shi Juan, Hsu Jason C, Luchsinger Larry, Hillyer Christopher D, Tseng Chien-Te K, Jiang Shibo, Du Lanying

机构信息

Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.

出版信息

Cell Res. 2020 Oct;30(10):932-935. doi: 10.1038/s41422-020-0387-5. Epub 2020 Aug 5.

DOI:10.1038/s41422-020-0387-5

PMID:32759966

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403570/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/755b/7403570/bf653eea9fd5/41422_2020_387_Fig1_HTML.jpg

相似文献

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.

Cell Res. 2020 Oct;30(10):932-935. doi: 10.1038/s41422-020-0387-5. Epub 2020 Aug 5.

A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice.

Cell Res. 2020 Oct;30(10):936-939. doi: 10.1038/s41422-020-00392-7. Epub 2020 Aug 17.

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.

Nature. 2020 Oct;586(7830):572-577. doi: 10.1038/s41586-020-2599-8. Epub 2020 Jul 29.

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.

Virol Sin. 2020 Jun;35(3):259-262. doi: 10.1007/s12250-020-00243-0. Epub 2020 Jun 10.

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.

J Transl Med. 2020 Jun 3;18(1):222. doi: 10.1186/s12967-020-02392-y.

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.

Emerg Microbes Infect. 2020 Dec;9(1):2076-2090. doi: 10.1080/22221751.2020.1821583.

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.

Immunity. 2020 Oct 13;53(4):724-732.e7. doi: 10.1016/j.immuni.2020.07.019. Epub 2020 Jul 30.

Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.

Vaccine. 2020 Nov 3;38(47):7533-7541. doi: 10.1016/j.vaccine.2020.09.061. Epub 2020 Sep 22.

Fast-and-fit vaccines.

Nat Biomed Eng. 2020 Aug;4(8):757-758. doi: 10.1038/s41551-020-00605-9.

Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection.

Chem Commun (Camb). 2020 Aug 7;56(61):8683-8686. doi: 10.1039/d0cc03263h. Epub 2020 Jul 2.

引用本文的文献

SARS-CoV-2 virus: Vaccines in development.

Fundam Res. 2021 Mar;1(2):131-138. doi: 10.1016/j.fmre.2021.01.009. Epub 2021 Jan 22.

Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development.

Mol Ther Nucleic Acids. 2025 Mar 28;36(2):102527. doi: 10.1016/j.omtn.2025.102527. eCollection 2025 Jun 10.

Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.

J Virol. 2025 May 20;99(5):e0229424. doi: 10.1128/jvi.02294-24. Epub 2025 Apr 23.

A SARS-CoV-2 vaccine on an NIR-II/SWIR emitting nanoparticle platform.

Sci Adv. 2025 Feb 7;11(6):eadp5539. doi: 10.1126/sciadv.adp5539.

Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.

PLoS Pathog. 2025 Jan 23;21(1):e1012456. doi: 10.1371/journal.ppat.1012456. eCollection 2025 Jan.

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.

Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.

Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.

J Virol. 2024 Sep 17;98(9):e0037624. doi: 10.1128/jvi.00376-24. Epub 2024 Aug 27.

Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.

bioRxiv. 2024 Jul 30:2024.07.30.605768. doi: 10.1101/2024.07.30.605768.

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV.

NPJ Vaccines. 2024 Jul 25;9(1):133. doi: 10.1038/s41541-024-00922-z.

An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity.

Int J Nanomedicine. 2024 Jul 17;19:7201-7214. doi: 10.2147/IJN.S463546. eCollection 2024.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.

作者信息

Tai Wanbo, Zhang Xiujuan, Drelich Aleksandra, Shi Juan, Hsu Jason C, Luchsinger Larry, Hillyer Christopher D, Tseng Chien-Te K, Jiang Shibo, Du Lanying

机构信息

Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.

出版信息

Cell Res. 2020 Oct;30(10):932-935. doi: 10.1038/s41422-020-0387-5. Epub 2020 Aug 5.

DOI:10.1038/s41422-020-0387-5

PMID:32759966

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403570/

Abstract

摘要

相似文献

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.

Cell Res. 2020 Oct;30(10):932-935. doi: 10.1038/s41422-020-0387-5. Epub 2020 Aug 5.

A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice.

Cell Res. 2020 Oct;30(10):936-939. doi: 10.1038/s41422-020-00392-7. Epub 2020 Aug 17.

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.

Nature. 2020 Oct;586(7830):572-577. doi: 10.1038/s41586-020-2599-8. Epub 2020 Jul 29.

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.

Virol Sin. 2020 Jun;35(3):259-262. doi: 10.1007/s12250-020-00243-0. Epub 2020 Jun 10.

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.

J Transl Med. 2020 Jun 3;18(1):222. doi: 10.1186/s12967-020-02392-y.

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.

Emerg Microbes Infect. 2020 Dec;9(1):2076-2090. doi: 10.1080/22221751.2020.1821583.

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.

Immunity. 2020 Oct 13;53(4):724-732.e7. doi: 10.1016/j.immuni.2020.07.019. Epub 2020 Jul 30.

Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.

Vaccine. 2020 Nov 3;38(47):7533-7541. doi: 10.1016/j.vaccine.2020.09.061. Epub 2020 Sep 22.

Fast-and-fit vaccines.

Nat Biomed Eng. 2020 Aug;4(8):757-758. doi: 10.1038/s41551-020-00605-9.

Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection.

Chem Commun (Camb). 2020 Aug 7;56(61):8683-8686. doi: 10.1039/d0cc03263h. Epub 2020 Jul 2.

引用本文的文献

SARS-CoV-2 virus: Vaccines in development.

Fundam Res. 2021 Mar;1(2):131-138. doi: 10.1016/j.fmre.2021.01.009. Epub 2021 Jan 22.

Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development.

Mol Ther Nucleic Acids. 2025 Mar 28;36(2):102527. doi: 10.1016/j.omtn.2025.102527. eCollection 2025 Jun 10.

Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.

J Virol. 2025 May 20;99(5):e0229424. doi: 10.1128/jvi.02294-24. Epub 2025 Apr 23.

A SARS-CoV-2 vaccine on an NIR-II/SWIR emitting nanoparticle platform.

Sci Adv. 2025 Feb 7;11(6):eadp5539. doi: 10.1126/sciadv.adp5539.

Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.

PLoS Pathog. 2025 Jan 23;21(1):e1012456. doi: 10.1371/journal.ppat.1012456. eCollection 2025 Jan.

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.

Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.

Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.

J Virol. 2024 Sep 17;98(9):e0037624. doi: 10.1128/jvi.00376-24. Epub 2024 Aug 27.

Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.

bioRxiv. 2024 Jul 30:2024.07.30.605768. doi: 10.1101/2024.07.30.605768.

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV.

NPJ Vaccines. 2024 Jul 25;9(1):133. doi: 10.1038/s41541-024-00922-z.

An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity.

Int J Nanomedicine. 2024 Jul 17;19:7201-7214. doi: 10.2147/IJN.S463546. eCollection 2024.

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.

作者信息

机构信息

出版信息

相似文献

引用本文的文献